{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:41:15Z","timestamp":1792003275435,"version":"4.4.0"},"reference-count":97,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"Korea government (MSIP; Ministry of Science, ICT &amp; Future Planning)","doi-asserted-by":"publisher","award":["2017R1C1B5018358"],"award-info":[{"award-number":["2017R1C1B5018358"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"Korea government (MSIP; Ministry of Science, ICT &amp; Future Planning)","doi-asserted-by":"publisher","award":["2021R1F1A1049784"],"award-info":[{"award-number":["2021R1F1A1049784"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"Korea government (MSIT; Ministry of Science and ICT)","doi-asserted-by":"publisher","award":["2017R1C1B5018358"],"award-info":[{"award-number":["2017R1C1B5018358"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"Korea government (MSIT; Ministry of Science and ICT)","doi-asserted-by":"publisher","award":["2021R1F1A1049784"],"award-info":[{"award-number":["2021R1F1A1049784"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Botulinum toxin (BoNT) is an anaerobic rod-shaped-neurotoxin produced by Clostridium botulinum, that has both therapeutic and lethal applications. BoNT injection is the most popular cosmetic procedure worldwide with various applications. Patients with dynamic wrinkles in areas such as the glabella, forehead, peri-orbital lines, nasal rhytides, and perioral rhytides are indicated. Excessive contraction of muscles or hyperactivity of specific muscles such as bulky masseters, cobble stone chins, gummy smiles, asymmetric smiles, and depressed mouth corners can achieve esthetic results by targeting the precise muscles. Patients with hypertrophic submandibular glands and parotid glands can also benefit esthetically. There are several FDA-approved BoNTs (obabotuli-numtoxinA, abobotulinumtoxinA, incobotulinumtoxinA, letibotulinumtoxinA, prabotulinumtox-inA, daxibotulinumtoxinA, rimbotulinumtoxinB) and novel BoNTs on the market. This paper is a narrative review of the consensus statements of expert practitioners and various literature on the injection points and techniques, highlighting both the Asian and Caucasian population separately. This paper can serve as a practical illustrative guide and reference for optimal, safe injection areas and effective doses for application of BoNT in the face and oral and maxillofacial area. The history of BoNT indications, contraindications, and complications, and the merits of ultrasonography (US)-assisted injections are also discussed.<\/jats:p>","DOI":"10.3390\/toxins15020082","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T04:28:47Z","timestamp":1673929727000},"page":"82","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Cosmetic Treatment Using Botulinum Toxin in the Oral and Maxillofacial Area: A Narrative Review of Esthetic Techniques"],"prefix":"10.3390","volume":"15","author":[{"given":"Sung Ok","family":"Hong","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Kyung Hee University College of Dentistry, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.asj.2008.03.003","article-title":"Nonsurgical reshaping of the lower face","volume":"28","author":"Liew","year":"2008","journal-title":"Aesthet. Surg. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cps.2011.03.012","article-title":"BeautiPHIcation\u2122: A global approach to facial beauty","volume":"38","author":"Swift","year":"2011","journal-title":"Clin. Plast. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00266-015-0562-0","article-title":"Consensus on changing trends, attitudes, and concepts of Asian beauty","volume":"40","author":"Liew","year":"2016","journal-title":"Aesthet. Plast. Surg."},{"key":"ref_4","first-page":"168","article-title":"Botulinum toxin injection for facial wrinkles","volume":"90","author":"Small","year":"2014","journal-title":"Am. Fam. Physician"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1064-7406(23)00393-0","article-title":"Anatomy and pathophysiology of facial aging","volume":"9","author":"Zimbler","year":"2001","journal-title":"Facial Plast. Surg. Clin. N. Am."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1038\/sj.bdj.2009.813","article-title":"Facial aesthetics: Is botulinum toxin treatment effective and safe? A systematic review of randomised controlled trials","volume":"207","author":"Gadhia","year":"2009","journal-title":"Br. Dent. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e15205","DOI":"10.1111\/dth.15205","article-title":"Emerging off-label esthetic uses of botulinum toxin in dermatology","volume":"35","author":"Phan","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40268-014-0077-1","article-title":"Pharmaceutical, biological, and clinical properties of botulinum neurotoxin type A products","volume":"15","author":"Frevert","year":"2015","journal-title":"Drugs R D"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s40257-020-00532-0","article-title":"Alternative clinical indications of botulinum toxin","volume":"21","author":"Alster","year":"2020","journal-title":"Am. J. Clin. Derm."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Serrera-Figallo, M.A., Ruiz-de-Le\u00f3n-Hern\u00e1ndez, G., Torres-Lagares, D., Castro-Araya, A., Torres-Ferrerosa, O., Hern\u00e1ndez-Pacheco, E., and Gutierrez-Perez, J.L. (2020). Use of Botulinum Toxin in Orofacial Clinical Practice. Toxins, 12.","DOI":"10.3390\/toxins12020112"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.27072","article-title":"Botulinum toxin: State of the art","volume":"32","author":"Jankovic","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2165\/11599840-000000000-00000","article-title":"Clinical relevance of botulinum toxin immunogenicity","volume":"26","author":"Benecke","year":"2012","journal-title":"BioDrugs"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: Medical and public health management","volume":"285","author":"Arnon","year":"2001","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-1331.2006.01438.x","article-title":"Pharmacology of botulinum toxin: Differences between type A preparations","volume":"13","author":"Rosales","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Choudhury, S., Baker, M.R., Chatterjee, S., and Kumar, H. (2021). Botulinum Toxin: An Update on Pharmacology and Newer Products in Development. Toxins, 13.","DOI":"10.3390\/toxins13010058"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"14130","DOI":"10.1038\/ncomms14130","article-title":"Identification and characterization of a novel botulinum neurotoxin","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jaad.2005.03.060","article-title":"Botulinum toxin type A","volume":"53","author":"Carruthers","year":"2005","journal-title":"J. Am. Acad. Derm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7002a1","article-title":"Clinical guidelines for diagnosis and treatment of botulism, 2021","volume":"70","author":"Rao","year":"2021","journal-title":"MMWR Recomm. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijom.2010.09.014","article-title":"The use of botulinum toxin type A in cosmetic facial procedures","volume":"40","author":"Jaspers","year":"2011","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40902-019-0218-0","article-title":"Application of botulinum toxin in maxillofacial field: Part I. Bruxism and square jaw","volume":"41","author":"Kwon","year":"2019","journal-title":"Maxillofac. Plast. Reconstr. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00266-010-9624-5","article-title":"Mandible changes evaluated by computed tomography following Botulinum Toxin A injections in square-faced patients","volume":"35","author":"Chang","year":"2011","journal-title":"Aesthet. Plast. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijom.2009.10.022","article-title":"Clinical use of botulinum toxins in oral and maxillofacial surgery","volume":"39","author":"Majid","year":"2010","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/mr.56.1.80-99.1992","article-title":"Properties and use of botulinum toxin and other microbial neurotoxins in medicine","volume":"56","author":"Schantz","year":"1992","journal-title":"Microbiol. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0161-6420(80)35127-0","article-title":"Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery","volume":"87","author":"Scott","year":"1980","journal-title":"Ophthalmology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.det.2009.08.001","article-title":"Botulinum toxin in facial rejuvenation: An update","volume":"27","author":"Carruthers","year":"2009","journal-title":"Derm. Clin."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1177\/0022034519875053","article-title":"Botulinum toxin type A in dental medicine","volume":"98","author":"Jabbari","year":"2019","journal-title":"J. Dent. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/dsu.12317","article-title":"Consensus recommendations on the aesthetic usage of botulinum toxin type A in Asians","volume":"39","author":"Ahn","year":"2013","journal-title":"Derm. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e872","DOI":"10.1097\/GOX.0000000000000507","article-title":"Aesthetic applications of botulinum toxin A in Asians: An international, multidisciplinary, Pan-Asian consensus","volume":"4","author":"Sundaram","year":"2016","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e1574","DOI":"10.1097\/GOX.0000000000001574","article-title":"Consensus recommendations for treatment strategies in Indians using botulinum toxin and Hyaluronic Acid fillers","volume":"5","author":"Kapoor","year":"2017","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00266-016-0608-y","article-title":"Consensus on current injectable treatment strategies in the Asian face","volume":"40","author":"Wu","year":"2016","journal-title":"Aesthet. Plast. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/17429590701523836","article-title":"Facial rejuvenation with botulinum neurotoxin: An anatomical and experiential perspective","volume":"9","author":"Fagien","year":"2007","journal-title":"J. Cosmet. Laser Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/jocd.12729","article-title":"Italian consensus report on the aesthetic use of onabotulinum toxin A","volume":"17","author":"Bertossi","year":"2018","journal-title":"J. Cosmet. Derm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1s","DOI":"10.1097\/01.PRS.0000144795.76040.D3","article-title":"Consensus recommendations on the use of botulinum toxin type a in facial aesthetics","volume":"114","author":"Carruthers","year":"2004","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5s","DOI":"10.1097\/PRS.0b013e31816de8d0","article-title":"Advances in facial rejuvenation: Botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies\u2014Consensus recommendations","volume":"121","author":"Carruthers","year":"2008","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/dsu.12148","article-title":"The convergence of medicine and neurotoxins: A focus on botulinum toxin type A and its application in aesthetic medicine\u2014A global, evidence-based botulinum toxin consensus education initiative: Part II: Incorporating botulinum toxin into aesthetic clinical practice","volume":"39","author":"Carruthers","year":"2013","journal-title":"Dermatol. Surg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/jocd.12003","article-title":"Global, 3-dimensional approach to natural rejuvenation: Part 1\u2014Recommendations for volume restoration and the periocular area","volume":"11","author":"Raspaldo","year":"2012","journal-title":"J. Cosmet. Derm."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/jocd.12035","article-title":"Global 3-dimensional approach to natural rejuvenation: Recommendations for perioral, nose, and ear rejuvenation","volume":"12","author":"Gassia","year":"2013","journal-title":"J. Cosmet. Derm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1473-2165.2011.00560.x","article-title":"Lower-face and neck antiaging treatment and prevention using onabotulinumtoxin A: The 2010 multidisciplinary French consensus\u2014Part 2","volume":"10","author":"Raspaldo","year":"2011","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1473-2165.2010.00544.x","article-title":"Upper- and mid-face anti-aging treatment and prevention using onabotulinumtoxin A: The 2010 multidisciplinary French consensus\u2014Part 1","volume":"10","author":"Raspaldo","year":"2011","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1468-3083.2010.03728.x","article-title":"International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)\u2014Part II: Wrinkles on the middle and lower face, neck and chest","volume":"24","author":"Ascher","year":"2010","journal-title":"J. Eur. Acad. Derm. Venereol."},{"key":"ref_41","first-page":"s7","article-title":"Expanding the use of neurotoxins in facial aesthetics: A consensus panel\u2019s assessment and recommendations","volume":"9","author":"Kane","year":"2010","journal-title":"J. Drugs Derm."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/j.1468-3083.2010.03631.x","article-title":"International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)\u2014Part I: Upper facial wrinkles","volume":"24","author":"Ascher","year":"2010","journal-title":"J. Eur. Acad. Derm. Venereol."},{"key":"ref_43","first-page":"297","article-title":"IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations","volume":"8","author":"Yutskovskaya","year":"2015","journal-title":"Clin. Cosmet. Investig. Derm."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"8s","DOI":"10.1177\/1090820X12455192","article-title":"Current aesthetic use of abobotulinumtoxinA in clinical practice: An evidence-based consensus review","volume":"32","author":"Maas","year":"2012","journal-title":"Aesthet. Surg. J."},{"key":"ref_45","first-page":"e1","article-title":"S1 guideline aesthetic botulinum toxin therapy","volume":"11","author":"Imhof","year":"2013","journal-title":"J. Dtsch. Derm. Ges."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"35s","DOI":"10.1177\/1090820X13480479","article-title":"Consensus panel\u2019s assessment and recommendations on the use of 3 botulinum toxin type A products in facial aesthetics","volume":"33","author":"Lorenc","year":"2013","journal-title":"Aesthet. Surg. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"518e","DOI":"10.1097\/01.prs.0000475758.63709.23","article-title":"Global Aesthetics Consensus: Botulinum Toxin Type A\u2014Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use, Including Updates on Complications","volume":"137","author":"Sundaram","year":"2016","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1097\/PRS.0000000000002119","article-title":"Global aesthetics consensus: Hyaluronic Acid billers and botulinum toxin type A-recommendations for combined treatment and optimizing outcomes in diverse patient populations","volume":"137","author":"Sundaram","year":"2016","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"265e","DOI":"10.1097\/PRS.0000000000003544","article-title":"Facial assessment and injection guide for botulinum toxin and injectable Hyaluronic Acid fillers: Focus on the upper Face","volume":"140","author":"Swift","year":"2017","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"540e","DOI":"10.1097\/PRS.0000000000003716","article-title":"Facial Assessment and Injection Guide for Botulinum toxin and injectable Hyaluronic Acid fillers: Focus on the midface","volume":"140","author":"DeBoulle","year":"2017","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"393e","DOI":"10.1097\/PRS.0000000000003646","article-title":"Facial assessment and injection guide for botulinum toxin and injectable Hyaluronic Acid fillers: Focus on the lower face","volume":"140","author":"Wu","year":"2017","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_52","first-page":"s5","article-title":"Re-examining the optimal use of neuromodulators and the changing landscape: A consensus panel update","volume":"19","author":"Kaminer","year":"2020","journal-title":"J. Drugs Derm."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/jocd.14728","article-title":"OnabotulinumtoxinA from lines to facial reshaping: A new Italian consensus report","volume":"21","author":"Signorini","year":"2022","journal-title":"J. Cosmet. Derm."},{"key":"ref_54","first-page":"011301","article-title":"Botulinum toxin type A for facial wrinkles","volume":"7","author":"Camargo","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"644e","DOI":"10.1097\/PRS.0000000000007762","article-title":"Current use of cosmetic toxins to improve facial aesthetics","volume":"147","author":"Janes","year":"2021","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Kim, H.-J., Seo, K.K., Lee, H.-K., and Kim, J. (2016). Clinical anatomy for botulinum toxin injection. Clinical Anatomy of the Face for Filler and Botulinum Toxin Injection, Springer.","DOI":"10.1007\/978-981-10-0240-3"},{"key":"ref_57","first-page":"549","article-title":"Complications, adverse reactions, and insights with the use of botulinum toxin","volume":"29","author":"Klein","year":"2003","journal-title":"Derm. Surg."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40902-019-0224-2","article-title":"Application of botulinum toxin in maxillofacial field: Part II. Wrinkle, intraoral ulcer, and cranio-maxillofacial pain","volume":"41","author":"Kwon","year":"2019","journal-title":"Maxillofac. Plast. Reconstr. Surg."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology","volume":"69","author":"Pirazzini","year":"2017","journal-title":"Pharm. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2147\/CCID.S160723","article-title":"Comparison of botulinum neurotoxin type A formulations in Asia","volume":"11","author":"Frevert","year":"2018","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s40265-021-01631-w","article-title":"Overview of DaxibotulinumtoxinA for injection: A novel formulation of botulinum toxin type A","volume":"81","author":"Solish","year":"2021","journal-title":"Drugs"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1128\/iai.64.5.1589-1594.1996","article-title":"Molecular composition of Clostridium botulinum type A progenitor toxins","volume":"64","author":"Inoue","year":"1996","journal-title":"Infect. Immun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1128\/aem.58.10.3426-3428.1992","article-title":"Stabilization of botulinum toxin type A during lyophilization","volume":"58","author":"Goodnough","year":"1992","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/DSS.0000000000001277","article-title":"Botulinum toxin in aesthetic medicine: Myths and realities","volume":"44","author":"Dover","year":"2018","journal-title":"Dermatol. Surg."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Kim, H.-J., Youn, K.-H., Kim, J.-S., Kim, Y.S., Hong, S.O., and Na, J. (2021). US applications in botulinum toxin injection procedures. Ultrasonographic Anatomy of the Face and Neck for Minimally Invasive Procedures: An Anatomic Guideline for Ultrasonographic-Guided Procedures, Springer.","DOI":"10.1007\/978-981-15-6560-1"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Kim, H.-J., Youn, K.-H., Kim, J.-S., Kim, Y.S., Hong, S.O., and Na, J. (2021). General US anatomy of the face and neck. Ultrasonographic Anatomy of the Face and Neck for Minimally Invasive Procedures: An Anatomic Guideline for Ultrasonographic-Guided Procedures, Springer.","DOI":"10.1007\/978-981-15-6560-1"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cps.2016.03.003","article-title":"Overview of botulinum toxins for aesthetic uses","volume":"43","author":"Gart","year":"2016","journal-title":"Clin. Plast. Surg."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajodo.2006.04.017","article-title":"Perceptions of dental professionals and laypersons to altered dental esthetics: Asymmetric and symmetric situations","volume":"130","author":"Kokich","year":"2006","journal-title":"Am. J. Orthod. Dentofac. Orthop."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/SCS.0000000000003099","article-title":"Physical therapy for smile improvement after orthognathic Surgery","volume":"28","author":"Hong","year":"2017","journal-title":"J. Craniofac. Surg."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jaad.2010.02.053","article-title":"Gummy smile and botulinum toxin: A new approach based on the gingival exposure area","volume":"63","author":"Mazzuco","year":"2010","journal-title":"J. Am. Acad. Derm."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2319\/091407-437.1","article-title":"Surface anatomy of the lip elevator muscles for the treatment of gummy smile using botulinum toxin","volume":"79","author":"Hwang","year":"2009","journal-title":"Angle Orthod."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/jocd.14858","article-title":"Efficacy of botulinum toxin in masseter muscle hypertrophy for lower face contouring","volume":"21","author":"Kundu","year":"2022","journal-title":"J. Cosmet. Derm."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/jocd.14160","article-title":"Complications of botulinum toxin, A. An update review","volume":"20","author":"Kroumpouzos","year":"2021","journal-title":"J. Cosmet. Derm."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/ca.23941","article-title":"Positional deformation of the parotid gland: Application to minimally invasive procedures","volume":"35","author":"Park","year":"2022","journal-title":"Clin. Anat."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bjp.0707375","article-title":"Intraglandular application of botulinum toxin leads to structural and functional changes in rat acinar cells","volume":"152","author":"Teymoortash","year":"2007","journal-title":"Br. J. Pharm."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1212\/01.WNL.0000101713.81253.4C","article-title":"A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson\u2019s disease","volume":"62","author":"Ondo","year":"2004","journal-title":"Neurology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.21213","article-title":"Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients","volume":"39","author":"Jackson","year":"2009","journal-title":"Muscle Nerve"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Kim, H.-J., Youn, K.-H., Kim, J.-S., Kim, Y.S., Hong, S.O., and Na, J. (2021). US Applications in filler injection procedures. Ultrasonographic Anatomy of the Face and Neck for Minimally Invasive Procedures: An Anatomic Guideline for Ultrasonographic-Guided Procedures, Springer.","DOI":"10.1007\/978-981-15-6560-1"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Kim, H.-J., Youn, K.-H., Kim, J.-S., Kim, Y.S., Hong, S.O., and Na, J. (2021). US applications in thread lifting procedures. Ultrasonographic Anatomy of the Face and Neck for Minimally Invasive Procedures: An Anatomic Guideline for Ultrasonographic-Guided Procedures, Springer.","DOI":"10.1007\/978-981-15-6560-1"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/asj\/sjy128","article-title":"Ultras.sound-guided botulinum neurotoxin type A injection for correcting asymmetrical smiles","volume":"38","author":"Lee","year":"2018","journal-title":"Aesthet. Surg. J."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Kim, D., Park, J.H., Favero, V., Mah, J., Jung, Y.S., and Kim, S.T. (2020). Effect of botulinum toxin injection on asymmetric lower face with chin deviation. Toxins, 12.","DOI":"10.3390\/toxins12070456"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00128071-200506030-00001","article-title":"Managing adverse events associated with botulinum toxin type A: A focus on cosmetic procedures","volume":"6","author":"Wollina","year":"2005","journal-title":"Am. J. Clin. Derm."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/asj\/sjac036","article-title":"Complications of cosmetic botulinum toxin A injections to the upper face: A systematic review and meta-analysis","volume":"42","author":"Zargaran","year":"2022","journal-title":"Aesthet. Surg. J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1007\/s00266-020-01983-w","article-title":"A review of Complications due to the use of botulinum toxin A for cosmetic indications","volume":"45","author":"Sethi","year":"2021","journal-title":"Aesthet. Plast. Surg."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Galadari, H., Galadari, I., Smit, R., Prygova, I., and Redaelli, A. (2021). Use of AbobotulinumtoxinA for cosmetic treatments in the neck, and middle and lower areas of the face: A systematic review. Toxins, 13.","DOI":"10.3390\/toxins13020169"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.toxicon.2014.02.004","article-title":"Type A botulinum neurotoxin complex proteins differentially modulate host response of neuronal cells","volume":"82","author":"Wang","year":"2014","journal-title":"Toxicon"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5999\/aps.2021.00766","article-title":"Immunogenicity of botulinum toxin","volume":"49","author":"Wee","year":"2022","journal-title":"Arch. Plast. Surg."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1212\/WNL.0000000000006688","article-title":"High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapy","volume":"92","author":"Albrecht","year":"2019","journal-title":"Neurology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e2079","DOI":"10.1097\/GOX.0000000000002079","article-title":"Safety and Efficacy of OnabotulinumtoxinA for Treatment of Crow\u2019s Feet Lines in Chinese Subjects","volume":"7","author":"Wu","year":"2019","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3109\/14764172.2012.738913","article-title":"A randomised, double-blind comparison of 20 units of onabotulinumtoxinA with 30 units of incobotulinumtoxinA for glabellar lines","volume":"14","author":"Dirschka","year":"2012","journal-title":"J. Cosmet. Laser Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/asj\/sjw272","article-title":"Liquid formulation of AbobotulinumtoxinA exhibits a favorable efficacy and safety profile in moderate to severe glabellar Lines: A randomized, double-blind, placebo- and active comparator-controlled trial","volume":"38","author":"Ascher","year":"2018","journal-title":"Aesthet. Surg. J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jaad.2009.01.005","article-title":"A single-center, dose-comparison, pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids: Safety and efficacy","volume":"60","author":"Carruthers","year":"2009","journal-title":"J. Am. Acad. Derm."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/DSS.0000000000000450","article-title":"Efficacy and safety of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results From a randomized, double-blind, placebo-controlled, phase III study","volume":"41","author":"Kerscher","year":"2015","journal-title":"Derm. Surg."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1097\/DSS.0000000000001920","article-title":"Efficacy and safety of Prabotulinumtoxin A and Onabotulinumtoxin A for Crow\u2019s feet: A phase 3, multicenter, randomized, double-blind, split-face study","volume":"45","author":"Cheon","year":"2019","journal-title":"Derm. Surg."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1111\/j.1524-4725.2010.01797.x","article-title":"Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg\/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: Satisfaction and patient-reported outcomes","volume":"36","author":"Carruthers","year":"2010","journal-title":"Dermatol. Surg."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/j.1524-4725.2012.02456.x","article-title":"OnabotulinumtoxinA dose-ranging study for hyperdynamic perioral lines","volume":"38","author":"Cohen","year":"2012","journal-title":"Derm. Surg."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/asj\/sjab015","article-title":"Onabotulinumtoxin Type A Dosage for upper face expression lines in males: A systematic review of current recommendations","volume":"41","author":"Kandhari","year":"2021","journal-title":"Aesthet. Surg. J."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/15\/2\/82\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:08:03Z","timestamp":1760119683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/15\/2\/82"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":97,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["toxins15020082"],"URL":"https:\/\/doi.org\/10.3390\/toxins15020082","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,17]]}}}